Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
103 Cards in this Set
- Front
- Back
amphotericin B and nystatin work by
|
bind to ergosterol, punch holes in the fungal cell wall
|
|
azoles work by
|
interfering with ergosterol synthesis (fungi)
|
|
fungi capsule can be visualized with
|
india ink stain
|
|
Malassezia furfur causes
|
pityriasis versicolor
|
|
une annonce
|
a notice, an announcement
|
|
Drug that binds to cell membrane sterols, especially ergosterol; form pores which irreversibly damage the membrane; intracellular ions (K, Mg) leak out.
|
Polyene antifungal agents:
Amphotericin B Nystatin, Natamycin |
|
Which drug forms pores in fungal cell membranes
|
Amphoterecin B
|
|
drugs that inhibit ergosterol synthesis
|
azole derivatives
terbinafine naftifine |
|
Which drug disrupts microtubles
|
griseofulvin
|
|
Which drug inhibits thymidylate synthetase
|
flucytosine
|
|
Which drugs inhibits squalene epoxidase
|
terbinafine
naftifine |
|
Adverse reactions of azole antifungal drugs include
|
hepatotoxicity
|
|
adverse reactions of Amphotericin B
|
Hypersensitivity, flushing, chills, fever, headache, pain, hypotension, convulsions, thrombophlebitis, hypokalemia, vomiting, impairment of renal function, anemia
|
|
Azoles decrease/increase P450 activity
|
decrease P450 activity
(cause increased bleeding when given with warfarin) |
|
Griseofulvin increases/decreases P450
|
increase P450
(the only antifungal drug that does this) |
|
What drug is used in conjunction with flucystosine
|
amphotericin B
|
|
drug for Candidal infections
|
Amphotericin B (topical)
|
|
drug for candidal infections of mucosa (mouth-oral monoliasis, esophagus, vaginal), skin, GI tract
(e.g.Candidis albicans) |
Nystatin
|
|
not absorbed from the gut; too toxic to use systemically
(use topically) |
Nystatin
|
|
Used topically as 5% ophthalmic suspension for fungal keratitis
|
Natamycin
|
|
Drug that is a primidine analog
|
Flucytosine (5FC, Ancobon)
|
|
Drug used to treat Candida, Cryptococcus, and some Aspergillus
|
Flucytosine
|
|
Drug that is toxic to bone marrow (anemia) and liver
|
Flucytosine
|
|
enterocolitis is an adverse reaction of
|
Flucytosine
|
|
ketoconazole
miconazole clotrimazole Class of drug? |
imidazole
|
|
what are the triazoles
|
fluconazole
itraconazole voriconazole posaconazole |
|
These agents inhibit sterol 14-alpha-demethylase, a P450-dependent enzyme essential for ergosterol synthesis
|
imidazole and triazole derivatives
|
|
Well absorbed from GI tract provided stomach contents remain acidic, though not used much for systemic infections.
|
ketoconazole
|
|
drug used to treat chronic mucocutaneous candidiasis, dermatophytes
|
ketoconazole
|
|
drug that Inhibits synthesis of adrenal and gonadal steroids (gynecomastia, infertility). Inhibits P450 enzymes.
|
ketoconazole
|
|
Hepatotoxic in 0.01%
|
ketoconazole
|
|
Clinical uses - Topical for a variety of cutaneous infections, cutaneous candidiasis and vulvovaginitis due to C. albicans
|
miconazole (monistat)
(an imidazole) |
|
Used for oropharyngeal candidiasis
|
clotrimazole
|
|
Orally effective for several fungal infections; particularly dermatophytoses and onychomycosis.
|
itraconazole
|
|
a triazole analog approved for primary treatment of aspergillosis; also candidiasis and filamentous fungi.
|
voriconazole
|
|
Adverse reactions include rash, alteration in liver enzymes, visual disturbances
|
voriconazole
|
|
a triazole analog approved for prevention and treatment of aspergillosis and candidiasis
|
posaconazole
|
|
Inhibits fungal cell mitosis by disrupting mitotic spindles from interaction with microtubules (binds to tubulin and microtubule associated protein).
|
griseofulvin
|
|
Used topical in treatment of Tinea cruris and Tinea corporis. Reduces ergosterol synthesis by inhibiting squalene-2,3-epoxidase.
|
naftifine
terbinifine |
|
these two drugs reduce ergosterol synthesis by inhibiting squalene-2,3-epoxidase.
|
naftifine
terbinafine |
|
Acts by inhibiting the synthesis of Beta(1-3) glucan in fungal cell walls. This results in cell death
|
caspofungin
|
|
An echinocandin approved for intravenous treatment of candida and invasive aspergillosis in patients who do NOT respond to Amphotericin B or voriconazole
|
caspofungin
|
|
Mechanism of Action - Transported into sensitive fungi by permease. Converted to 5-fluorouracil (5-FU), then to 5-fluorodeoxyuridylate (FdUMP), a competitive inhibitor of thymidylate synthetase, which impairs DNA synthesis AND fluorouridine triphosphate (FUTP), an inhibitor of RNA synthesis.
|
flucytosine
|
|
drugs that are restrict to topical use due to toxicity
|
the imidazoles
(ketoconazole, miconazole, clotrimazole) |
|
Only _____ can form germ tubes
|
Candida albicans
|
|
Aspergillis is feared in _____ patients
|
cancer
|
|
are dimorphic fungi contagious?
|
Yes! Are contagious
|
|
First line of defense against fungi?
|
Neutrophils
|
|
Candida albicans can interfere with
|
complement binding
|
|
dimorphic fungi evade
|
phagocyte killing
|
|
Histoplasma multiplies inside
|
phagocytes (macrophages, neutrophils)
|
|
Important in HIV infected patients in Southeast Asia and China
|
penicillium marneffei
|
|
Histoplasma is a dimorphic fungus growing in the yeast phase in tissues and in temps over
|
37 celsius
|
|
epidemiological links of Histoplasma
|
Puerto Rico
Bats Spelunkers Ohio and mississippi river |
|
Histoplasmas grown within
|
mACROPHAGES AND NEUTROPHILS
|
|
grow in the lung leading to lesions similar to tuberculosis
|
Histoplasmas
|
|
Histoplasma drug of choice
|
Itraconazole
|
|
present in the southwestern US and Northern Mexico deserts
|
Coccidioides
|
|
Valley Fever associated with
|
Coccidioides
|
|
dissemination leads to meningitis or osteomyelitis
|
Coccidiodies
|
|
Coccidioides drug of choice
|
fluconazole
|
|
Geographic distribution includes the middle (Ohio and Mississippi valley)and south east part of the US (Virginia and the Carolinas)
Also southeastern Canada (Quebec and Nova Scotia) |
Blastomyces
|
|
Histoplasma : intracellular / extracellular
|
intracellular
|
|
Blastomyces: intracellular / extracellular
|
extracellular
|
|
Complement is not effective at opsonizing
|
Coccidiodes
|
|
Complement, antibody and cell mediated immunity are all involved
|
Blastomyces
|
|
It is geographically limited to Central and South America
80% of all cases world wide are found in Brazil |
Paracoccidioides brasiliensis
|
|
Paracoccidioides brasiliensis drug of choice
|
trimethoprim/sulfamethoxazole
|
|
Smooth colonies form over night resembling Staphylococci
|
Candida
|
|
procedure to differentiate C. albicans from the other Candida species
|
germ tube production
|
|
first line defense against Candida
|
neutrophils
|
|
Seen in people with T-cell mediated immune defects
|
Chronic mucocutaneous candidiasis
|
|
Candida drug of choice
|
Fluconazole
|
|
can produce melanin which protects them from oxidation by phagocytes
|
Cryptococcus
|
|
has a strong affinity for the central nervous system
|
Cryptococcus
|
|
The capsule binds mucicarmine and appears red
|
cryptococcus
|
|
stain for cryptococcus
|
india ink
mucicarmine stain |
|
Cryptococcus treatment
|
Meningitis
Amphotericin B + flucytosine until asymptomatic Followed by fluconazole indefinitely Repeat lumbar punctures to decrease the intracranial pressure may be beneficial All other forms of Cryptococcosis Fluconazole is drug of choice |
|
exists as a sporocyte
|
Pneumocystis jiroveci (carnii)
|
|
The major surface glycoprotein (MSG) functions as an attachment ligand
|
Pneumocystis jiroveci
|
|
extracellular existence within the alveoli
|
Pneumocystic jiroveci
|
|
first line of defense against Pneumocystic jiroveci
|
alveolar macrophages
|
|
Pneumocystic jiroveci causes
|
Pneumonia which is slowly progressive over 3-4 weeks
Non productive cough, dyspnea Extrapulmonary findings are extremely rare |
|
diagnosis of Pneumocystic jiroveci
|
The organism cannot be cultured
Can stain the bronchoalveolar lavage fluid (BAL) Usually stained by methenamine silver |
|
Pneumocystic jiroveci treatment of choice
|
trimethoprim/sulfamethoxazole
|
|
Apergillus
Septate / Non-septate |
septate
|
|
zygomycetes
Septate / Non-septate |
Non-septate
|
|
are angioinvasive
|
Aspergillus
The hyphae have a tendency to invade vasculature and can lead to infarction of tissue |
|
first line of defense against Aspergillus
|
Alveolar macrophages
|
|
treatment of Aspergilloma
|
sclerosis of the bleeding vessel or surgical removal of the cavity and aspergilloma
*Antifungal therapy is not indicated |
|
treatment of Allergic Bronchopulmonary Aspergillosis
|
steroids, albuterol
*antifungals contraindicated |
|
treatment of Invasive Aspergillosis
|
The drug of choice is voriconazole
Alternatives include itraconazole or a lipid formulation of amphotericin B Surgical debulking is almost always necessary |
|
zygomycetes include
|
Rhizopus and Mucor
|
|
Aseptate, irregular 90o branching, broad, ribbon-like hyphae
|
zygomycetes (Rhizopus and Mucor)
|
|
45o Angle Branching & Septate Hyphae
|
Aspergillus
|
|
zygomycetes found in
|
soil, bread and other food
|
|
have a predilection for low pH and are seen in patients with acidosis, either from diabetes or other organic acids (lactate)
|
zygomycetes (Rhizopus and mucor)
|
|
sequester iron which is a major virulence factor for this organism
|
zygomycetes (Rhizopus and mucor)
|
|
zygomycetes (Rhizopus and mucor) causes
|
rhinocerebral infection or pulmonary infection
cutaneous infection and is followed by dissemination rapidly invades tissue and can lead to destruction of blood vessels that lead to tissue necrosis (fatal) |
|
Headache
Orbital cellulitis/hemorrhage Cranial nerve palsy Vascular thrombosis Coma Death clinical manifestations of |
zygomycetes (Rhizopus and mucor)
|
|
treatment of zygomycetes
|
Amphotericin B
posaconazole |
|
treatment of Hyalohyphomycoses & Phaeohyphomycoses
|
surgical debulking
Amphotericin B |
|
rarely cause disease but When a patient gets one of these infections, it is almost always lethal
|
Hyalohyphomycoses & Phaeohyphomycoses
|